Latest Breaking News On - Cash amount - Page 3 : comparemela.com

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2 3352 and $2 5879 in Cash Per Share Plus a Contingent Value Right

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2 3352 and $2 5879 in Cash Per Share Plus a Contingent Value Right
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Rowen hughesKinnate biopharmaJuliane snowdenKathy vincentExchange commissionKinnate biopharma incDunn crutcherAcquire kinnate biopharmaCash per share plusContingent valueBase priceCash amountChief executive officerMerger agreementRecommendation statementInvestor relations

XOMA (XOMA) to Acquire Kinnate Biopharma (KNTE) for Between $2 3352 and $2 5879 in Cash Per Share Plus a Contingent Value Right

XOMA (XOMA) to Acquire Kinnate Biopharma (KNTE) for Between $2 3352 and $2 5879 in Cash Per Share Plus a Contingent Value Right
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rowen hughesDunn crutcherKinnate biopharma incXoma corporationKinnate biopharmaBase priceCash amountChief executive officerMerger agreement

Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals

As previously announced on December 22, 2023, Concentra Biosciences, LLC and its wholly owned subsidiary, Concentra Merger Sub II, Inc. , entered into a merger agreement with Theseus.

United statesConcentra merger sub ii incConcentra biosciencesTheseus pharmaceuticals incMorrow sodaliBroadridge corporate issuer solutionsConcentra merger subTheseus pharmaceuticalsPrice perBase priceContingent value rightsMerger agreementAdditional price per shareCash amountCorporate issuer solutionsTender offer statement

Cyclo Therapeutics : Material Event - Form 8-K -December 18, 2023 at 06:13 am EST

Item 8.01 Other Events. Other Events As previously announced, on September 21, 2023, Cyclo Therapeutics, Inc. and Cameo Merger Sub, Inc., a Delaware corporation.

United statesAaron vandevenderTahir mahmoodWilson sonsini goodrich rosatiPc wilson sonsiniCameo merger sub incRafael holdings incClementia pharmaceuticalsSavara pharmaceuticalsMolecular transport incReneo pharmaceuticalsKalvista pharmaceuticalsCensa pharmaceuticalsAlexion pharmaceuticalsAudit committeeParty transaction

Form 485APOS BlackRock ETF Trust

Form 485APOS BlackRock ETF Trust
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalSan franciscoUnited kingdomNew yorkCornell universityState of new yorkWinterthur museumHoly family instituteNew york stock exchangeState of wyomingDistrict of columbiaUniversity schoolLiberty squareUniversity of delawareCity of new york